Aspiring investors and financial enthusiasts alike are always keen to gain insights into the strategies of the world’s most successful investors. With their vast wealth and unparalleled experience, billionaire investors are often viewed as beacons of wisdom in the stock market. Today we’ll take a closer look at three stocks that have caught the attention of billionaire investors, offering a glimpse into their investment portfolios and potential opportunities for investors looking to follow in their footsteps.
Here are three stocks investment legends have been buying recently –
Gates Industrial Corporation plc – SYM: GTES
Recent Price: $11.43
Legends: Paul Tudor Jones, Jim Simons, Charles Brandes
Description: Gates Industrial Corporation plc manufactures and sells engineered power transmission and fluid power solutions worldwide. It operates in two segments, Power Transmission and Fluid Power. Gates Industrial Corporation plc was founded in 1911 and is headquartered in Denver, Colorado.
Rather, it’s a little-known alternative investment that could hand you big monthly income from oil and gas.
Find Out What It Is Right Here
Cool Company Ltd. – SYM: CLCO
Recent Price: $13.72
Legends: Donald Smith & Co., Jim Simons, Azvalor Managers FL
Description: Cool Company Ltd. engages in the ownership, operation, and management of liquefied natural gas carriers (LNGCs) that provides supply chain support solutions for energy industry. The company owns and operates a fleet of LNGCs, including tri-fuel diesel electric vessels; and floating storage and regasification units for third parties. Cool Company Ltd. was incorporated in 2018 and is headquartered in Hamilton, Bermuda.
Bausch + Lomb Corporation – SYM: BLCO
Recent Price: $16.75
Legends: Jim Simons, Charles Brandes, Mario Gabelli
Description: Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products for therapeutic use, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, dry eye, and redness relief. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.